Phaseline

Targets › O2

O2: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 3; Neurology; next expected readout Aug 2028.

Open in Phaseline: the race on O2, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of South FloridaOxygen 99.7%
Hyperbaric oxygen therapy (HBOT) at 2.0 ATA delivering 100% oxygen
O2Phase 3Traumatic Brain InjuryAug 2028

Conditions

Traumatic Brain Injury (1)

Modalities

small molecule (1)

Companies

University of South Florida (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.